Health Care [ 8/12 ] | Health Care Equipment & Supplies [ 61/73 ]
NASDAQ | Common Stock
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States.
The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand.
It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations.
The company markets and sells its products online through its website www.MangoRX.com.
The company was incorporated in 2021 and is headquartered in Dallas, Texas.
Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 15, 25 | -1.05 Increased by +32.49% | - |
| Mar 20, 25 | -1.08 Increased by +39.95% | - |
| Sep 30, 24 | -0.99 Increased by +41.44% | - |
| Jun 30, 24 | -1.37 Increased by +32.96% | - |
| Mar 31, 24 | -1.56 Decreased by -576.26% | - |
| Dec 31, 23 | -1.80 Decreased by -2.90 K% | - |
| Sep 30, 23 | -1.70 Decreased by -8.38 K% | - |
| Jun 30, 23 | -2.05 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 109.31 K Decreased by -48.95% | -4.84 M Decreased by -104.35% | Decreased by -4.43 K% Decreased by -300.25% |
| Dec 31, 24 | 105.25 K Decreased by -56.93% | -1.95 M Increased by +24.14% | Decreased by -1.85 K% Decreased by -76.13% |
| Sep 30, 24 | 133.37 K Decreased by -45.60% | -2.00 M Decreased by -11.12% | Decreased by -1.50 K% Decreased by -104.26% |
| Jun 30, 24 | 163.16 K Increased by +15.52% | -2.39 M Decreased by -4.68% | Decreased by -1.47 K% Increased by +9.38% |
| Mar 31, 24 | 214.09 K Increased by +112.56% | -2.37 M Increased by +7.54% | Decreased by -1.11 K% Increased by +56.50% |
| Dec 31, 23 | 244.37 K Increased by +2.63 K% | -2.57 M Decreased by -281.21% | Decreased by -1.05 K% Increased by +86.06% |
| Sep 30, 23 | 245.16 K Increased by +N/A% | -1.80 M Decreased by -80.80% | Decreased by -733.81% Decreased by N/A% |
| Jun 30, 23 | 141.24 K Increased by +N/A% | -2.28 M Decreased by -594.22% | Decreased by -1.62 K% Decreased by N/A% |